Remove DNA Remove Science Remove Virus
article thumbnail

Engineering viruses to kill deadly pathogens

Science Daily: Pharmacology News

In the new study, researchers successfully modified DNA from four types of phages to kill a deadly pathogen. Antimicrobial resistance is an urgent and growing global crisis. Researchers are exploring phages, viruses that infect bacteria, as a possible solution.

Virus 104
article thumbnail

A virus that infected the first animals hundreds of millions of years ago has become essential for the development of the embryo

SCIENMAG: Medicine & Health

Viral genetic material was integrated into the genome of the first multi-cellular beings and is still in our DNA today. Researchers from the CNIO (Spanish National Cancer Research Centre) describe now in the journal Science […]

Virus 69
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Improving viral vector safety for gene therapies

Drug Discovery World

Dr Andrea O’Hara, Senior Product Manager at Azenta Life Sciences asks why integration site analysis (ISA) is critical for the safety and efficacy of viral vectors for gene therapy. While many different modalities of delivery vectors exist, the two most common viral vectors are lentivirus and adeno-associated virus.

Therapies 147
article thumbnail

Lipid nanoparticles and mRNA used to treat hereditary blindness

Drug Discovery World

The study, led by OSU Associate Professor of Pharmaceutical Sciences Gaurav Sahay, Oregon State doctoral student Marco Herrera-Barrera, and Oregon Health & Science University Assistant Professor of Ophthalmology Renee Ryals, was published in Science Advances. .

article thumbnail

Eterna acquires Exacis’ allogeneic immuno-oncology platform

Drug Discovery World

Eterna Therapeutics, a life science company focused on mRNA cell engineering, has acquired Exacis Biotherapeutics’ immuno-oncology platform. In contrast to DNA-based reprogramming and gene editing, the mRNA-based approach does not expose cells to expensive and potentially harmful viruses or DNA vectors.

article thumbnail

Drug discovery and development trends – what will have most impact?

Drug Discovery World

Hosted by DDW and sponsored by DNA Script, join us for this free-to-attend roundtable to learn about the biggest opportunities for the future of drug discovery and development. Will AI be key to expediting the drug discovery process and what role will data science have? What can we expect from the cell & gene therapy market?

DNA 130
article thumbnail

Join this exclusive DDW roundtable on drug discovery trends

Drug Discovery World

Hosted by DDW and supported by DNA Script, ‘Drug discovery and development trends – what will have most impact?’ Will AI be key to expediting the drug discovery process and what role will data science have? will be free to attend on June 28 at 8AM PT | 11AM ET | 4PM BST | 5PM CET. What changes can we expect from clinical trials?

DNA 130